Latest Microbix Biosystems (MBXBF) Headlines eResearch

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Latest Microbix Biosystems (MBXBF) Headlines

eResearch Posts Update Report on Microbix Biosystems Inc.
ACCESSWIRE - Wed Feb 26, 1:52PM CST
Microbix Biosystems Inc. focuses on developing and commercializing biological products and technologies through leveraging its Core Base Business of developing infectious disease antigens (virology) for sale to large diagnostic kit manufacturers.

eResearch Posts Perspective on Microbix Biosystems Inc.
ACCESSWIRE - Mon Jan 27, 6:27AM CST
Microbix Biosystems Inc. focuses on developing and commercializing biological products and technologies through leveraging its Core Base Business of developing infectious disease antigens (virology) for sale to large diagnostic kit manufacturers.

IIROC Trading Halt / Suspension de la négociation par l'OCRCVM - Microbix Biosystems Inc., MBX
Marketwire Canada - Thu Jan 23, 11:49AM CST
Trading resumes in / Reprise des negociations pour :

IIROC Trade Resumption - Microbix Biosystems Inc.
Newsfile Corp - Thu Jan 23, 10:57AM CST
Trading resumes in:

Competitor Analysis: Thrombolytics & Fibrinolytics
M2 - Mon May 20, 3:46AM CDT
Research and Markets (http://www.researchandmarkets.com/research/j3c6qc/competitor) has announced the addition of the "Competitor Analysis: Thrombolytics & Fibrinolytics" report to their offering. The Competitive Intelligence Report Thrombolytics & Fibrinolytics as of May 2013 provides a competitor analysis in the product portfolios and development pipelines of novel thrombolytics and fibrinolytics for treatment of cardiovascular thrombosis, stroke and eye diseases. Purchase of the pdf report includes a 6-month online access to the data of the report and any updates since the publication date. Credentials to access the database will be sent by e-mail and allow online work with the project data to print or export an individual report. The report provides information on the various generation of marketed thrombolytics and includes a compilation of current active projects in research and development of novel thrombolytics and fibrinolytics including those in development in ophthalmology and in less regulated markets. In addition, the report lists company-specific product portfolios and R&D pipelines of thrombolytics and fibrinolytics. Competitor projects are listed in a tabular format providing information on: - Drug Codes, - Target / Mechanism of Action, - Class of Compound, - Company, - Product Category, - Indication, - R&D Stage and - additional comments with a hyperlink leading to the source of information. Examples of Companies Mentioned - Actavis - Alcon - Astellas Pharma - Bharat Biotech - Biocon - BioGeneric Pharma - Cadila Pharma - Cerbios Pharma - Cerevast Therapeutics - CSL Behring - Dexa Medica - Eisai - Ekos Corp - Grifols - Heber Biotec - Kedrion - Kee Pharma - Lundbeck - Microbix Biosystems - Mitsubishi Tanabe Pharma - Nanogen Biopharmaceuticals - ProteomTech - Pulse Therapeutics - Roche (Genentech) - Shantha Biotechnics (Sanofi) - Techpool BioPharma - Thrombogenics - Zydus Cadila For more information visit http://www.researchandmarkets.com/research/j3c6qc/competitor About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Microbix reports fiscal 2013 first quarter results
CNW Group - Thu Feb 14, 6:30AM CST
Company Provides Update on Product Pipeline

Microbix Sells Purified Water Business
CNW Group - Fri Feb 01, 6:30AM CST
Microbix Biosystems Inc. (TSX: MBX), a biotechnology company developing innovative biological products and technologies, today announced it has sold its Water-for-Injection business to Irvine Scientific in California. The sale was constructed on an earn-out basis, though specific deal terms were not disclosed.

Microbix' LumiSort Patent Upheld in U.S.
CNW Group - Fri Jan 25, 6:25AM CST
Sexing Technologies fails in second attempt to invalidate claims

Microbix Refiles Financial Statements
CNW Group - Thu Jan 10, 4:41PM CST
Microbix Biosystems Inc. (TSX:MBX) today refiled its financial statements for the year ended September 30, 2012 to correct two oversights in the Consolidated Statements of Comprehensive Loss.

Microbix Reports 15% Increase In Virology Product Sales In 2012
CNW Group - Fri Dec 28, 10:33PM CST
Urokinase, Vaccine Venture, and LumiSort Update

Microbix Biosystems (MBXBF) Stock Research Links

MBXBF Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Bladex Declares Quarterly Dividend for Q3 2026

Updated Category News Views 85

Bladex's Steady Dividend: What's Under the Hood? Well, well, it looks like Bladex is doing the old dividend dance again. They've just announced a quarterly cash dividend of $0.6875 per share for the third quarter of 2026. It's scheduled for payout on November 24 to those who have their noses in the ledger come November 6—that's your record date, folks. Now, dividends...

Continue Reading
Bybit’s Gold Yield Offer: 2.83% APR on XAUT

Updated Category News Views 41

Gold Savings with a Tokenized Twist Taking a wild swing at pairing gold and crypto in a digestible package, Bybit and the XAUE Protocol have teamed up to offer a 2.83% fixed APR on XAUT Savings. If you're itching for something that doesn’t make your stomach churn like some of the wild crypto rides, this just might soothe those nerves. Or maybe it’s just a slick way to...

Continue Reading
Essential Oils Market Booms; Hits $29.52Bn by 2031

Updated Category News Views 90

Essential Oils: Aromatherapy's New Frontier and Pharma Ally What’s the deal with essential oils? Well, it seems they’re not just for your neighbor’s pricey diffuser anymore. According to some fresh numbers, we're staring down a market worth nearly $30 billion by 2031. And it ain't all incense and hippie stores fueling this beast — we're talking a serious expansion...

Continue Reading
Anti-Corruption Titans Gather for Key 20-Year IAACA Event

Updated Category News Views 35

Strength in Unity: A Global Anti-Corruption Gathering Here's a scene you don't stumble upon every day: corruption busters from all corners of the globe converging on Marrakech. The International Association of Anti-Corruption Authorities (IAACA) is rolling out the red carpet for its 20th-anniversary conference, a get-together poised to serve up not just pastries and...

Continue Reading
Coulomb Solutions Powers Ahead with ReadyGrid Launch

Updated Category News Views 25

Breaking New Ground with ReadyGrid If you've been keeping an eye on the energy storage landscape, today's a big day. Coulomb Solutions, Inc. (CSI) is shaking things up by spinning off ReadyGrid, its own dedicated mobile energy storage powerhouse. The move is designed to tackle the pressing power challenges that have been nagging industries across the board, from...

Continue Reading
Big Tree Cloud Files Annual Report, Eyes AI Expansion

Updated Category News Views 82

Annual Reports and Long-Term Vision God, does the stock market love itself some annual filings. Anyway, Big Tree Cloud Holdings Limited (NASDAQ: DSY) just went and did their annual rigmarole with the 20-F form for the fiscal year ending June 2026. Filed with the SEC, they're letting shareholders and the interested masses know—plainly, and probably...

Continue Reading
Workers at CertainTeed Plant Unionize with Teamsters

Updated Category News Views 218

Unity at CertainTeed Sends Ripples through Industry Here's something that'll stir your coffee: 170 workers at CertainTeed's fiberglass facility in Chowchilla, California, just decided they won't take management's antics lying down. These folks voted to join Teamsters Local 431, aiming for some long-overdue respect and a contract that'll guarantee better wages and...

Continue Reading
Sands China's Latest Move: A Bond Offering Twist

Updated Category News Views 74

Breaking Down Sands China's Bond Maneuver Today, we found out that Sands China is teeing up a fresh round of senior unsecured notes. Now, if that doesn't get your ticker flickin', maybe you're too used to market snoozefests. The folks at the helm of Sands China, a subsidiary under the mighty Las Vegas Sands Corp. (NYSE: LVS), are rolling out these USD-denominated notes...

Continue Reading
Tempo's Protein Max Meals: A High-Protein Revolution

Updated Category News Views 8

Packed Protein, Zero Hassle Every once in a while, something comes along in the food sector that changes the game. Tempo's Protein Max meals might just be it. Launching with a hefty 40 grams of protein in every serving, these meals promise a powerful punch for anyone who's serious about meeting their protein counts without spending hours in the kitchen. Two minutes flat...

Continue Reading
Steel Vet Shift: John Pritchett Takes Helm at Trojan

Updated Category News Views 6

Trojan Steel's Bold Move with John Pritchett at the Helm Trojan Steel is changing the game by appointing John C. Pritchett as its new President. This isn't just another shuffle of suits in the boardroom—it's a statement. Pritchett isn't some steel industry old-timer; instead, he's a business leader with a knack for scaling operations. With a resume that includes...

Continue Reading

Top 5 Most Recently Viewed Articles

Pepe Heimer Unveils Revolutionary AI-Driven DeFi Solutions

Updated Category News Views 221

Pepe Heimer Revolutionizes DeFi with AI Innovations Pepe Heimer recently made headlines with the introduction of its AI-powered yield optimization tools, launching a new memecoin designed to meld the vibrant world of meme culture with practical utility. Positioned uniquely within the decentralized finance (DeFi) sector, Pepe Heimer is not just another flavor of memecoin;...

Continue Reading
Investigation into Neumora Therapeutics by Faruqi & Faruqi, LLP

Updated Category News Views 128

Investigation of Neumora Therapeutics Faruqi & Faruqi, LLP, a prominent national securities law firm, is actively investigating potential claims on behalf of investors in Neumora Therapeutics, Inc. (NASDAQ: NMRA). The firm is reaching out to those who may have incurred significant financial losses related to this biotechnology company's operations and recent public...

Continue Reading
Exciting Launch: Truly Hard Seltzer and JaNa Craig Unveil New Flavor

Updated Category News Views 255

Introducing No Shade, Just Tea It’s an exciting time for seltzer fans! Truly Hard Seltzer has partnered with the charismatic reality star JaNa Craig to bring us a brand new flavor: No Shade, Just Tea. This limited-edition seltzer is set to capture hearts and taste buds alike with its unique combination of raspberry and brewed tea, making it a delightful choice for...

Continue Reading
Market Insights: Trends in Tech and Investor Favorites

Updated Category News Views 291

Understanding Recent Market Trends Recently, the stock market has seen significant fluctuations that have affected some of the most favored companies among investors. The S&P 500 experienced its sharpest weekly decline in over a year, highlighting the current volatility impacting various sectors. Analysis of Major Declines The recent drop in the S&P 500, as tracked by the...

Continue Reading
Potential Class Action Against NANO Nuclear Energy, Inc.

Updated Category News Views 87

Act Now, NANO Nuclear Energy Investors For those invested in NANO Nuclear Energy, Inc. (NASDAQ: NNE), there’s a chance to lead a securities fraud lawsuit. If you acquired securities during the specified class period, you might qualify for compensation based on recent updates in the case. Investors are encouraged to act promptly since important deadlines are coming up....

Continue Reading